Publications

publication October 30, 2014

Structure/Function Claims and Other Claim Notifications: An Achilles Heel for Industry

‘Structure/Function Claims and Other Claim Notifications: An Achilles Heel for Industry,’ by Abhishek Gurnani, Natural Products Insider, September/October 2014.

publication October 1, 2014

The Importance of Quality Control Agreements in the Dietary Supplement Industry

‘The Importance of Quality Control Agreements in the Dietary Supplement Industry,’ by Abhishek Gurnani, Natural Products Insider, September/October 2014.

publication August 4, 2014

Treading the Clean Label Trend

‘Treading the Clean Label Trend,’ by Abhishek Gurnani, Natural Products Insider, July/August 2014.

publication July 16, 2014

“Industry Beware—FDA is Watching Tweets and Posts”

‘Industry Beware—FDA is Watching Tweets and Posts,’ by Jacqueline Kuler, Natural Products Insider, July  2014.

publication June 6, 2014

FSMA Gives FDA Emergency Access to Records

‘FSMA Gives FDA Emergency Access to Records,’ by Abhishek Gurnani, Natural Products Insider, May/June 2014.

publication January 31, 2014

FDA Showcases Mandatory Recall Powers Under FSMA

‘FDA Showcases Mandatory Recall Powers Under FSMA,’ by Abhishek Gurnani, Natural Products Insider, January 2014.

publication February 19, 2013

What the Dietary Supplement Industry Needs to Know About the New U.S. Patent Laws

“What the Dietary Supplement Industry Needs to Know About the New U.S. Patent Laws,” by Rakesh Amin, Natural Products Insider, February 2013. Under the America Invents Act (AIA), the U.S. patent laws were amended in ways that represent the biggest changes in decades to U.S. patent law. The most significant changes of the AIA are […]

publication February 13, 2013

Dietary Supplement Regulation in the United States

‘Dietary Supplement Regulation in the United States,’ co-authored by Rend Al-Mondhiry, Springer International Publishing, 2013.

What's Now

Ivan Wasserman Quoted in “FDA Shakeup: Makary Steps Down, Diamantas Steps Up”

In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.

see all news >